Mast cell-deficient KitW-sh "sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5534-5544

  Michel, Anastasija ^a   Schüler, Andrea ^a   Friedrich, Pamela ^a   Döner, Fatma ^a   Bopp, Tobias ^a   Radsak, Markus ^a   Hoffmann, Markus ^a   Relle, Manfred ^a   Distler, Ute ^a   Kuharev, Jörg ^a   Tenzer, Stefan ^a   Feyerabend, Thorsten B ^b   Rodewald, Hans Reimer ^b   Schild, Hansjörg ^a   Schmitt, Edgar ^a   Becker, Marc ^a   Stassen, Michael ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL TRANSFER; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE RESPONSE; EXTRAMEDULLARY HEMATOPOIESIS; IMMUNE RESPONSE; IN VITRO STUDY; LUNG ALVEOLUS CELL CARCINOMA; MAST CELL; MOUSE; MUTATION; MYELOID DERIVED SUPPRESSOR CELL; MYELOID PROGENITOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; SUPPRESSOR CELL; TUMOR GROWTH;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; FEMALE; HEMATOPOIESIS, EXTRAMEDULLARY; IMMUNOPHENOTYPING; MAST CELLS; MICE; MICE, KNOCKOUT; MUTATION; MYELOID CELLS; MYELOPOIESIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; SPLEEN;

EID: 84878089252     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203355     Document Type: Article

References (55)

1. Broudy, V. C. 1997. Stem cell factor and hematopoiesis. Blood 90: 1345-1364. (Pubitemid 27355406)
2. Ashman, L. K. 1999. The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol. 31: 1037-1051. (Pubitemid 29454545)
3. Chabot, B., D. A. Stephenson, V. M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335: 88-89.
4. Geissler, E. N., M. A. Ryan, and D. E. Housman. 1988. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185-192.
5. Nocka, K., J. C. Tan, E. Chiu, T. Y. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9: 1805-1813.
6. Zsebo, K. M., D. A. Williams, E. N. Geissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R.-Y. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock, et al. 1990. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224.
7. Pittoni, P., S. Piconese, C. Tripodo, and M. P. Colombo. 2011. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene 30: 757-769.
8. Galli, S. J., and Y. Kitamura. 1987. Genetically mast-cell-deficient W/Wv and Sl/Sld mice. Their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127: 191-198. (Pubitemid 17062601)
9. v mice and their increase by bone marrow transplantation. Blood 52: 447-452.
10. sh) at the W-locus and a spontaneous recessive lethal in mice. Genet. Res. 39: 315-322.
11. Duttlinger, R., K. Manova, T. Y. Chu, C. Gyssler, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1993. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118: 705-717. (Pubitemid 23232779)
12. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848.
13. Wolters, P. J., J. Mallen-St Clair, C. C. Lewis, S. A. Villalta, P. Baluk, D. J. Erle, and G. H. Caughey. 2005. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-sh/KitW-sh sash mice. Clin. Exp. Allergy 35: 82-88. (Pubitemid 40188275)
14. Duttlinger, R., K. Manova, G. Berrozpe, T. Y. Chu, V. DeLeon, I. Timokhina, R. S. Chaganti, A. D. Zelenetz, R. F. Bachvarova, and P. Besmer. 1995. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. USA 92: 3754-3758.
15. sh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173: 1693-1701.
16. Berrozpe, G., V. Agosti, C. Tucker, C. Blanpain, K. Manova, and P. Besmer. 2006. A distant upstream locus control region is critical for expression of the Kit receptor gene in mast cells. Mol. Cell. Biol. 26: 5850-5860. (Pubitemid 44134339)
17. Yamazaki, M., T. Tsujimura, E. Morii, K. Isozaki, H. Onoue, S. Nomura, and Y. Kitamura. 1994. C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression. Blood 83: 3509-3516.
18. 57, and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 94: 2658-2666.
19. Heib, V., M. Becker, C. Taube, and M. Stassen. 2008. Advances in the understanding of mast cell function. Br. J. Haematol. 142: 683-694.
20. Beaven, M. A. 2009. Our perception of the mast cell from Paul Ehrlich to now. Eur. J. Immunol. 39: 11-25.
21. Dudeck, A., J. Dudeck, J. Scholten, A. Petzold, S. Surianarayanan, A. Köhler, K. Peschke, D. Vöhringer, C. Waskow, T. Krieg, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34: 973-984.
22. Feyerabend, T. B., A. Weiser, A. Tietz, M. Stassen, N. Harris, M. Kopf, P. Radermacher, P. Möller, C. Benoist, D. Mathis, et al. 2011. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 35: 832-844.
23. Katz, H. R., and K. F. Austen. 2011. Mast cell deficiency, a game of kit and mouse. Immunity 35: 668-670.
24. Brown, M. A., J. K. Hatfield, M. E. Walker, and B. A. Sayed. 2012. A game of kit and mouse: the Kit is still in the bag. Immunity 36: 891-892, author reply 893-894.
25. Rodewald, H.-R., and T. B. Feyerabend. 2012. Widespread immunological functions of mast cells: fact or fiction? Immunity 37: 13-24.
26. Becker, M., S. Reuter, P. Friedrich, F. Doener, A. Michel, T. Bopp, M. Klein, E. Schmitt, H. Schild, M. P. Radsak, et al. 2011. Genetic variation determines mast cell functions in experimental asthma. J. Immunol. 186: 7225-7231.
27. Aguilo, F., S. Avagyan, A. Labar, A. Sevilla, D.-F. Lee, P. Kumar, I. R. Lemischka, B. Y. Zhou, and H.-W. Snoeck. 2011. Prdm16 is a physiologic regulator of hematopoietic stem cells. Blood 117: 5057-5066.
28. Pronk, C. J. H., O. P. Veiby, D. Bryder, and S. E. W. Jacobsen. 2011. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J. Exp. Med. 208: 1563-1570.
29. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197. (Pubitemid 30154488)
30. Wiśniewski, J. R., A. Zougman, N. Nagaraj, and M. Mann. 2009. Universal sample preparation method for proteome analysis. Nat. Methods 6: 359-362.
31. Tenzer, S., D. Docter, S. Rosfa, A. Wlodarski, J. Kuharev, A. Rekik, S. K. Knauer, C. Bantz, T. Nawroth, C. Bier, et al. 2011. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5: 7155-7167.
32. Silva, J. C., R. Denny, C. A. Dorschel, M. Gorenstein, I. J. Kass, G.-Z. Li, T. McKenna, M. J. Nold, K. Richardson, P. Young, and S. Geromanos. 2005. Quantitative proteomic analysis by accurate mass retention time pairs. Anal. Chem. 77: 2187-2200. (Pubitemid 40463836)
33. Geromanos, S. J., J. P. C. Vissers, J. C. Silva, C. A. Dorschel, G.-Z. Li, M. V. Gorenstein, R. H. Bateman, and J. I. Langridge. 2009. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics 9: 1683-1695.
34. Giles, K., S. D. Pringle, K. R. Worthington, D. Little, J. L. Wildgoose, and R. H. Bateman. 2004. Applications of a travelling wave-based radiofrequency-only stacked ring ion guide. Rapid Commun. Mass Spectrom. 18: 2401-2414. (Pubitemid 39361780)
35. W-sh mice does not impair antibody-mediated arthritis. J. Exp. Med. 204: 2797-2802.
36. Passegué, E., C. H. Jamieson, L. E. Ailles, and I. L. Weissman. 2003. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. USA 100(Suppl 1): 11842-11849. (Pubitemid 37205893)
37. Wilson, A., G. M. Oser, M. Jaworski, W. E. Blanco-Bose, E. Laurenti, C. Adolphe, M. A. Essers, H. R. Macdonald, and A. Trumpp. 2007. Dormant and self-renewing hematopoietic stem cells and their niches. Ann. N. Y. Acad. Sci. 1106: 64-75. (Pubitemid 47443057)
38. Bao, Y., and X. Cao. 2011. Revisiting the protective and pathogenic roles of neutrophils: Ly-6G is key! Eur. J. Immunol. 41: 2535-2538.
39. Biermann, H., B. Pietz, R. Dreier, K. W. Schmid, C. Sorg, and C. Sunderkötter. 1999. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J. Leukoc. Biol. 65: 217-231. (Pubitemid 29077015)
40. Greifenberg, V., E. Ribechini, S. Rössner, and M. B. Lutz. 2009. Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development. Eur. J. Immunol. 39: 2865-2876.
41. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
42. Cuenca, A. G., M. J. Delano, K. M. Kelly-Scumpia, C. Moreno, P. O. Scumpia, D. M. Laface, P. G. Heyworth, P. A. Efron, and L. L. Moldawer. 2011. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol. Med. 17: 281-292.
43. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
44. Youn, J.-I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
45. Youn, J. I., M. Collazo, I. N. Shalova, S. K. Biswas, and D. I. Gabrilovich. 2012. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91: 167-181.
46. Yuhas, J. M., R. E. Toya, and E. Wagner. 1975. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma. Cancer Res. 35: 242-244.
47. Ugel, S., F. Delpozzo, G. Desantis, F. Papalini, F. Simonato, N. Sonda, S. Zilio, and V. Bronte. 2009. Therapeutic targeting of myeloid-derived suppressor cells. Curr. Opin. Pharmacol. 9: 470-481.
48. Kao, J., E. C. Ko, S. Eisenstein, A. G. Sikora, S. Fu, and S.-H. Chen. 2011. Targeting immune suppressing myeloid-derived suppressor cells in oncology. Crit. Rev. Oncol. Hematol. 77: 12-19.
49. sh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood 80: 1448-1453.
50. Kimura, Y., B. Ding, N. Imai, D. J. Nolan, J. M. Butler, and S. Rafii. 2011. c-Kit-mediated functional positioning of stem cells to their niches is essential for maintenance and regeneration of adult hematopoiesis. PLoS ONE 6: e26918.
51. Mazo, I. B., S. Massberg, and U. H. von Andrian. 2011. Hematopoietic stem and progenitor cell trafficking. Trends Immunol. 32: 493-503.
52. Pan, P.-Y., G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen. 2008. Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 111: 219-228.
53. Ribatti, D., and E. Crivellato. 2011. Mast cells, angiogenesis, and tumour growth. Biochim. Biophys. Acta 1822: 2-8.
54. Dalton, D. K., and R. J. Noelle. 2012. The roles of mast cells in anticancer immunity. Cancer Immunol. Immunother. 61: 1511-1520.
55. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.